Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 37 to 48 of 276 entries
Sorted by: Best Match Show Resources per page
Three-dimensional versus standard miniplate, lag screws versus miniplates, locking plate versus non-locking miniplates: Management of mandibular fractures, a systematic review and meta-analysis.

Journal of dental sciences

Wusiman P, Taxifulati D, Weidong L, Moming A.
PMID: 30988882
J Dent Sci. 2019 Mar;14(1):66-80. doi: 10.1016/j.jds.2018.04.004. Epub 2019 Jan 14.

BACKGROUND/PURPOSE: The aims of the present study were to 1) evaluate the clinical outcomes between different fixation methods in the management of mandibular fractures (MFs) and 2) determine which fixation method is the best option for the treatment of...

Cite
Wusiman P, Taxifulati D, Weidong L, et al. Three-dimensional versus standard miniplate, lag screws versus miniplates, locking plate versus non-locking miniplates: Management of mandibular fractures, a systematic review and meta-analysis. J Dent Sci. 2019;14(1):66-80doi: 10.1016/j.jds.2018.04.004.
Wusiman, P., Taxifulati, D., Weidong, L., & Moming, A. (2019). Three-dimensional versus standard miniplate, lag screws versus miniplates, locking plate versus non-locking miniplates: Management of mandibular fractures, a systematic review and meta-analysis. Journal of dental sciences, 14(1), 66-80. https://doi.org/10.1016/j.jds.2018.04.004
Wusiman, Patiguli, et al. "Three-dimensional versus standard miniplate, lag screws versus miniplates, locking plate versus non-locking miniplates: Management of mandibular fractures, a systematic review and meta-analysis." Journal of dental sciences vol. 14,1 (2019): 66-80. doi: https://doi.org/10.1016/j.jds.2018.04.004
Wusiman P, Taxifulati D, Weidong L, Moming A. Three-dimensional versus standard miniplate, lag screws versus miniplates, locking plate versus non-locking miniplates: Management of mandibular fractures, a systematic review and meta-analysis. J Dent Sci. 2019 Mar;14(1):66-80. doi: 10.1016/j.jds.2018.04.004. Epub 2019 Jan 14. PMID: 30988882; PMCID: PMC6445977.
Copy Download .nbib Format: NLM
A versatile radiotherapy treatment chair.

The British journal of radiology

Karzmark CJ, Bagshaw MA, Huisman PA, Lawson J.
PMID: 7437733
Br J Radiol. 1980 Dec;53(636):1190-4. doi: 10.1259/0007-1285-53-636-1190.

No abstract available.

Cite
Karzmark CJ, Bagshaw MA, Huisman PA, et al. A versatile radiotherapy treatment chair. Br J Radiol. 1980;53(636):1190-4doi: 10.1259/0007-1285-53-636-1190.
Karzmark, C. J., Bagshaw, M. A., Huisman, P. A., & Lawson, J. (1980). A versatile radiotherapy treatment chair. The British journal of radiology, 53(636), 1190-4. https://doi.org/10.1259/0007-1285-53-636-1190
Karzmark, C J, et al. "A versatile radiotherapy treatment chair." The British journal of radiology vol. 53,636 (1980): 1190-4. doi: https://doi.org/10.1259/0007-1285-53-636-1190
Karzmark CJ, Bagshaw MA, Huisman PA, Lawson J. A versatile radiotherapy treatment chair. Br J Radiol. 1980 Dec;53(636):1190-4. doi: 10.1259/0007-1285-53-636-1190. PMID: 7437733.
Copy Download .nbib Format: NLM
Towards community-driven metadata standards for light microscopy: tiered specifications extending the OME model.

Nature methods

Hammer M, Huisman M, Rigano A, Boehm U, Chambers JJ, Gaudreault N, North AJ, Pimentel JA, Sudar D, Bajcsy P, Brown CM, Corbett AD, Faklaris O, Lacoste J, Laude A, Nelson G, Nitschke R, Farzam F, Smith CS, Grunwald D, Strambio-De-Castillia C.
PMID: 34862501
Nat Methods. 2021 Dec;18(12):1427-1440. doi: 10.1038/s41592-021-01327-9.

No abstract available.

Cite
Hammer M, Huisman M, Rigano A, et al. Towards community-driven metadata standards for light microscopy: tiered specifications extending the OME model. Nat Methods. 2021;18(12):1427-1440doi: 10.1038/s41592-021-01327-9.
Hammer, M., Huisman, M., Rigano, A., Boehm, U., Chambers, J. J., Gaudreault, N., North, A. J., Pimentel, J. A., Sudar, D., Bajcsy, P., Brown, C. M., Corbett, A. D., Faklaris, O., Lacoste, J., Laude, A., Nelson, G., Nitschke, R., Farzam, F., Smith, C. S., Grunwald, D., & Strambio-De-Castillia, C. (2021). Towards community-driven metadata standards for light microscopy: tiered specifications extending the OME model. Nature methods, 18(12), 1427-1440. https://doi.org/10.1038/s41592-021-01327-9
Hammer, Mathias, et al. "Towards community-driven metadata standards for light microscopy: tiered specifications extending the OME model." Nature methods vol. 18,12 (2021): 1427-1440. doi: https://doi.org/10.1038/s41592-021-01327-9
Hammer M, Huisman M, Rigano A, Boehm U, Chambers JJ, Gaudreault N, North AJ, Pimentel JA, Sudar D, Bajcsy P, Brown CM, Corbett AD, Faklaris O, Lacoste J, Laude A, Nelson G, Nitschke R, Farzam F, Smith CS, Grunwald D, Strambio-De-Castillia C. Towards community-driven metadata standards for light microscopy: tiered specifications extending the OME model. Nat Methods. 2021 Dec;18(12):1427-1440. doi: 10.1038/s41592-021-01327-9. PMID: 34862501.
Copy Download .nbib Format: NLM
Supporting the Imperfect Use of Amplified Pain Syndrome-Reply.

JAMA pediatrics

Weisman A, Quintner J, Masharawi Y.
PMID: 34125154
JAMA Pediatr. 2021 Sep 01;175(9):977-978. doi: 10.1001/jamapediatrics.2021.1491.

No abstract available.

Cite
Weisman A, Quintner J, Masharawi Y. Supporting the Imperfect Use of Amplified Pain Syndrome-Reply. JAMA Pediatr. 2021;175(9):977-978doi: 10.1001/jamapediatrics.2021.1491.
Weisman, A., Quintner, J., & Masharawi, Y. (2021). Supporting the Imperfect Use of Amplified Pain Syndrome-Reply. JAMA pediatrics, 175(9), 977-978. https://doi.org/10.1001/jamapediatrics.2021.1491
Weisman, Asaf, et al. "Supporting the Imperfect Use of Amplified Pain Syndrome-Reply." JAMA pediatrics vol. 175,9 (2021): 977-978. doi: https://doi.org/10.1001/jamapediatrics.2021.1491
Weisman A, Quintner J, Masharawi Y. Supporting the Imperfect Use of Amplified Pain Syndrome-Reply. JAMA Pediatr. 2021 Sep 01;175(9):977-978. doi: 10.1001/jamapediatrics.2021.1491. PMID: 34125154.
Copy Download .nbib Format: NLM
CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancer.

Research square

Huang A, Bange E, Han N, Wileyto EP, Kim J, Gouma S, Robinson J, Greenplate A, Porterfield F, Owoyemi O, Naik K, Zheng C, Galantino M, Weisman A, Ittner C, Kugler E, Baxter A, Weirick M, McAllister C, Babady NE, Kumar A, Widman A, Dewolf S, Boutemine S, Roberts C, Budzik K, Tollett S, Wright C, Perloff T, Sun L, Mathew D, Giles J, Oldridge D, Wu J, Alanio C, Adamski S, Vella L, Kerr S, Cohen J, Oyer R, Massa R, Maillard I, Maxwell K, Maslak P, Vonderheide R, Wolchok JD, Hensley S, Wherry E, Meyer N, DeMichele A, Vardhana S, Mamtani R, Oniyide O, Agyekum R, Dunn T, Jones T, Giannini H, Garfall A, Reilly J.
PMID: 33564756
Res Sq. 2021 Feb 02; doi: 10.21203/rs.3.rs-162289/v1.

Cancer patients have increased morbidity and mortality from Coronavirus Disease 2019 (COVID-19), but the underlying immune mechanisms are unknown. In a cohort of 100 cancer patients hospitalized for COVID-19 at the University of Pennsylvania Health System, we found that...

Cite
Huang A, Bange E, Han N, et al. CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancer. Res Sq. 2021;doi: 10.21203/rs.3.rs-162289/v1.
Huang, A., Bange, E., Han, N., Wileyto, E. P., Kim, J., Gouma, S., Robinson, J., Greenplate, A., Porterfield, F., Owoyemi, O., Naik, K., Zheng, C., Galantino, M., Weisman, A., Ittner, C., Kugler, E., Baxter, A., Weirick, M., McAllister, C., Babady, N. E., Kumar, A., Widman, A., Dewolf, S., Boutemine, S., Roberts, C., Budzik, K., Tollett, S., Wright, C., Perloff, T., Sun, L., Mathew, D., Giles, J., Oldridge, D., Wu, J., Alanio, C., Adamski, S., Vella, L., Kerr, S., Cohen, J., Oyer, R., Massa, R., Maillard, I., Maxwell, K., Maslak, P., Vonderheide, R., Wolchok, J. D., Hensley, S., Wherry, E., Meyer, N., DeMichele, A., Vardhana, S., Mamtani, R., Oniyide, O., Agyekum, R., Dunn, T., Jones, T., Giannini, H., Garfall, A., & Reilly, J. (2021). CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancer. Research square, . https://doi.org/10.21203/rs.3.rs-162289/v1
Huang, Alexander, et al. "CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancer." Research square vol. (2021). doi: https://doi.org/10.21203/rs.3.rs-162289/v1
Huang A, Bange E, Han N, Wileyto EP, Kim J, Gouma S, Robinson J, Greenplate A, Porterfield F, Owoyemi O, Naik K, Zheng C, Galantino M, Weisman A, Ittner C, Kugler E, Baxter A, Weirick M, McAllister C, Babady NE, Kumar A, Widman A, Dewolf S, Boutemine S, Roberts C, Budzik K, Tollett S, Wright C, Perloff T, Sun L, Mathew D, Giles J, Oldridge D, Wu J, Alanio C, Adamski S, Vella L, Kerr S, Cohen J, Oyer R, Massa R, Maillard I, Maxwell K, Maslak P, Vonderheide R, Wolchok JD, Hensley S, Wherry E, Meyer N, DeMichele A, Vardhana S, Mamtani R, Oniyide O, Agyekum R, Dunn T, Jones T, Giannini H, Garfall A, Reilly J. CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancer. Res Sq. 2021 Feb 02; doi: 10.21203/rs.3.rs-162289/v1. PMID: 33564756; PMCID: PMC7872363.
Copy Download .nbib Format: NLM
Protection against autoimmunity is driven by thymic epithelial cell-mediated regulation of T.

Science immunology

Haftmann C, Zwicky P, Ingelfinger F, Mair F, Floess S, Riedel R, Durek P, Spalinger MR, Friebel E, Leung BP, Lutz M, Puertas N, Amorim A, Schärli S, Becher B, Kisielow J, Waisman A, Mashreghi MF, Huehn J, Becher B.
PMID: 34797691
Sci Immunol. 2021 Nov 19;6(65):eabf3111. doi: 10.1126/sciimmunol.abf3111. Epub 2021 Nov 19.

[Figure: see text].

Cite
Haftmann C, Zwicky P, Ingelfinger F, et al. Protection against autoimmunity is driven by thymic epithelial cell-mediated regulation of T. Sci Immunol. 2021;6(65):eabf3111doi: 10.1126/sciimmunol.abf3111.
Haftmann, C., Zwicky, P., Ingelfinger, F., Mair, F., Floess, S., Riedel, R., Durek, P., Spalinger, M. R., Friebel, E., Leung, B. P., Lutz, M., Puertas, N., Amorim, A., Schärli, S., Becher, B., Kisielow, J., Waisman, A., Mashreghi, M. F., Huehn, J., & Becher, B. (2021). Protection against autoimmunity is driven by thymic epithelial cell-mediated regulation of T. Science immunology, 6(65), eabf3111. https://doi.org/10.1126/sciimmunol.abf3111
Haftmann, Claudia, et al. "Protection against autoimmunity is driven by thymic epithelial cell-mediated regulation of T." Science immunology vol. 6,65 (2021): eabf3111. doi: https://doi.org/10.1126/sciimmunol.abf3111
Haftmann C, Zwicky P, Ingelfinger F, Mair F, Floess S, Riedel R, Durek P, Spalinger MR, Friebel E, Leung BP, Lutz M, Puertas N, Amorim A, Schärli S, Becher B, Kisielow J, Waisman A, Mashreghi MF, Huehn J, Becher B. Protection against autoimmunity is driven by thymic epithelial cell-mediated regulation of T. Sci Immunol. 2021 Nov 19;6(65):eabf3111. doi: 10.1126/sciimmunol.abf3111. Epub 2021 Nov 19. PMID: 34797691.
Copy Download .nbib Format: NLM
Deep learning-assisted prostate cancer detection on bi-parametric MRI: minimum training data size requirements and effect of prior knowledge.

European radiology

Hosseinzadeh M, Saha A, Brand P, Slootweg I, de Rooij M, Huisman H.
PMID: 34786615
Eur Radiol. 2021 Nov 16; doi: 10.1007/s00330-021-08320-y. Epub 2021 Nov 16.

OBJECTIVES: To assess Prostate Imaging Reporting and Data System (PI-RADS)-trained deep learning (DL) algorithm performance and to investigate the effect of data size and prior knowledge on the detection of clinically significant prostate cancer (csPCa) in biopsy-naïve men with...

Cite
Hosseinzadeh M, Saha A, Brand P, et al. Deep learning-assisted prostate cancer detection on bi-parametric MRI: minimum training data size requirements and effect of prior knowledge. Eur Radiol. 2021;doi: 10.1007/s00330-021-08320-y.
Hosseinzadeh, M., Saha, A., Brand, P., Slootweg, I., de Rooij, M., & Huisman, H. (2021). Deep learning-assisted prostate cancer detection on bi-parametric MRI: minimum training data size requirements and effect of prior knowledge. European radiology, . https://doi.org/10.1007/s00330-021-08320-y
Hosseinzadeh, Matin, et al. "Deep learning-assisted prostate cancer detection on bi-parametric MRI: minimum training data size requirements and effect of prior knowledge." European radiology vol. (2021). doi: https://doi.org/10.1007/s00330-021-08320-y
Hosseinzadeh M, Saha A, Brand P, Slootweg I, de Rooij M, Huisman H. Deep learning-assisted prostate cancer detection on bi-parametric MRI: minimum training data size requirements and effect of prior knowledge. Eur Radiol. 2021 Nov 16; doi: 10.1007/s00330-021-08320-y. Epub 2021 Nov 16. PMID: 34786615.
Copy Download .nbib Format: NLM
Neonatal resuscitation in the NICU; Challenges beyond NRP.

Acta paediatrica (Oslo, Norway : 1992)

Gover A, Levy PT, Zaltsberg-Barak T, Rotschild A, Molad M, Lavie-Nevo K, Waisman D.
PMID: 34347316
Acta Paediatr. 2021 Dec;110(12):3269-3271. doi: 10.1111/apa.16057. Epub 2021 Aug 11.

No abstract available.

Cite
Gover A, Levy PT, Zaltsberg-Barak T, et al. Neonatal resuscitation in the NICU; Challenges beyond NRP. Acta Paediatr. 2021;110(12):3269-3271doi: 10.1111/apa.16057.
Gover, A., Levy, P. T., Zaltsberg-Barak, T., Rotschild, A., Molad, M., Lavie-Nevo, K., & Waisman, D. (2021). Neonatal resuscitation in the NICU; Challenges beyond NRP. Acta paediatrica (Oslo, Norway : 1992), 110(12), 3269-3271. https://doi.org/10.1111/apa.16057
Gover, Ayala, et al. "Neonatal resuscitation in the NICU; Challenges beyond NRP." Acta paediatrica (Oslo, Norway : 1992) vol. 110,12 (2021): 3269-3271. doi: https://doi.org/10.1111/apa.16057
Gover A, Levy PT, Zaltsberg-Barak T, Rotschild A, Molad M, Lavie-Nevo K, Waisman D. Neonatal resuscitation in the NICU; Challenges beyond NRP. Acta Paediatr. 2021 Dec;110(12):3269-3271. doi: 10.1111/apa.16057. Epub 2021 Aug 11. PMID: 34347316.
Copy Download .nbib Format: NLM
Dedifferentiated secretory breast carcinoma with fibrosarcomatous features harboring an ETV6-NTRK3 fusion in both components.

Genes, chromosomes & cancer

Xu J, Weisman P.
PMID: 33342011
Genes Chromosomes Cancer. 2021 Jun;60(6):447-451. doi: 10.1002/gcc.22929. Epub 2020 Dec 28.

Secretory carcinomas are low-grade translocation-driven carcinomas occurring in patients over a wide age range. These tumors most frequently arise in the breast and salivary gland, but may occasionally arise at other anatomic sites, such as the skin, the thyroid...

Cite
Xu J, Weisman P. Dedifferentiated secretory breast carcinoma with fibrosarcomatous features harboring an ETV6-NTRK3 fusion in both components. Genes Chromosomes Cancer. 2020;60(6):447-451doi: 10.1002/gcc.22929.
Xu, J., & Weisman, P. (2021). Dedifferentiated secretory breast carcinoma with fibrosarcomatous features harboring an ETV6-NTRK3 fusion in both components. Genes, chromosomes & cancer, 60(6), 447-451. https://doi.org/10.1002/gcc.22929
Xu, Jin, and Weisman, Paul. "Dedifferentiated secretory breast carcinoma with fibrosarcomatous features harboring an ETV6-NTRK3 fusion in both components." Genes, chromosomes & cancer vol. 60,6 (2021): 447-451. doi: https://doi.org/10.1002/gcc.22929
Xu J, Weisman P. Dedifferentiated secretory breast carcinoma with fibrosarcomatous features harboring an ETV6-NTRK3 fusion in both components. Genes Chromosomes Cancer. 2021 Jun;60(6):447-451. doi: 10.1002/gcc.22929. Epub 2020 Dec 28. PMID: 33342011.
Copy Download .nbib Format: NLM
Clinical evaluation of the SD Biosensor SARS-CoV-2 saliva antigen rapid test with symptomatic and asymptomatic, non-hospitalized patients.

PloS one

Igloi Z, Velzing J, Huisman R, Geurtsvankessel C, Comvalius A, IJpelaar J, van Beek J, Ensing R, Boelsums T, Koopmans M, Molenkamp R.
PMID: 34936659
PLoS One. 2021 Dec 22;16(12):e0260894. doi: 10.1371/journal.pone.0260894. eCollection 2021.

BACKGROUND: Performance of the SD Biosensor saliva antigen rapid test was evaluated at a large designated testing site in non-hospitalized patients, with or without symptoms.METHOD: All eligible people over 18 years of age presenting for a booked appointment at...

Cite
Igloi Z, Velzing J, Huisman R, et al. Clinical evaluation of the SD Biosensor SARS-CoV-2 saliva antigen rapid test with symptomatic and asymptomatic, non-hospitalized patients. PLoS One. 2021;16(12):e0260894doi: 10.1371/journal.pone.0260894.
Igloi, Z., Velzing, J., Huisman, R., Geurtsvankessel, C., Comvalius, A., IJpelaar, J., van Beek, J., Ensing, R., Boelsums, T., Koopmans, M., & Molenkamp, R. (2021). Clinical evaluation of the SD Biosensor SARS-CoV-2 saliva antigen rapid test with symptomatic and asymptomatic, non-hospitalized patients. PloS one, 16(12), e0260894. https://doi.org/10.1371/journal.pone.0260894
Igloi, Zsofia, et al. "Clinical evaluation of the SD Biosensor SARS-CoV-2 saliva antigen rapid test with symptomatic and asymptomatic, non-hospitalized patients." PloS one vol. 16,12 (2021): e0260894. doi: https://doi.org/10.1371/journal.pone.0260894
Igloi Z, Velzing J, Huisman R, Geurtsvankessel C, Comvalius A, IJpelaar J, van Beek J, Ensing R, Boelsums T, Koopmans M, Molenkamp R. Clinical evaluation of the SD Biosensor SARS-CoV-2 saliva antigen rapid test with symptomatic and asymptomatic, non-hospitalized patients. PLoS One. 2021 Dec 22;16(12):e0260894. doi: 10.1371/journal.pone.0260894. eCollection 2021. PMID: 34936659.
Copy Download .nbib Format: NLM
Glycaemic control in transition-aged versus early adults with type 1 diabetes and the effect of a government-funded insulin pump programme.

Diabetic medicine : a journal of the British Diabetic Association

Mooney SP, Booth GL, Shulman R, Na Y, Weisman A, Shah BR, Perkins BA, Lipscombe L.
PMID: 34076916
Diabet Med. 2021 Nov;38(11):e14618. doi: 10.1111/dme.14618. Epub 2021 Jun 16.

AIM: To compare glycaemic control and adverse outcomes between transition-aged and early adults with type 1 diabetes, and the impact of continuous subcutaneous insulin infusion (CSII) therapy funded through a government Assisted Devices Program.METHODS: This retrospective cohort study using...

Cite
Mooney SP, Booth GL, Shulman R, et al. Glycaemic control in transition-aged versus early adults with type 1 diabetes and the effect of a government-funded insulin pump programme. Diabet Med. 2021;38(11):e14618doi: 10.1111/dme.14618.
Mooney, S. P., Booth, G. L., Shulman, R., Na, Y., Weisman, A., Shah, B. R., Perkins, B. A., & Lipscombe, L. (2021). Glycaemic control in transition-aged versus early adults with type 1 diabetes and the effect of a government-funded insulin pump programme. Diabetic medicine : a journal of the British Diabetic Association, 38(11), e14618. https://doi.org/10.1111/dme.14618
Mooney, Shane P, et al. "Glycaemic control in transition-aged versus early adults with type 1 diabetes and the effect of a government-funded insulin pump programme." Diabetic medicine : a journal of the British Diabetic Association vol. 38,11 (2021): e14618. doi: https://doi.org/10.1111/dme.14618
Mooney SP, Booth GL, Shulman R, Na Y, Weisman A, Shah BR, Perkins BA, Lipscombe L. Glycaemic control in transition-aged versus early adults with type 1 diabetes and the effect of a government-funded insulin pump programme. Diabet Med. 2021 Nov;38(11):e14618. doi: 10.1111/dme.14618. Epub 2021 Jun 16. PMID: 34076916.
Copy Download .nbib Format: NLM
Exclusive Expression of MyD88 on Dendritic Cells Is Lopez Kostka Sufficient to Induce Protection against Experimental Leishmaniasis.

The Journal of investigative dermatology

Lopez Kostka S, Kautz-Neu K, Yogev N, Lukas D, Holzmann B, Waisman A, Clausen BE, von Stebut E.
PMID: 34570998
J Invest Dermatol. 2021 Sep 24; doi: 10.1016/j.jid.2021.07.184. Epub 2021 Sep 24.

No abstract available.

Cite
Lopez Kostka S, Kautz-Neu K, Yogev N, et al. Exclusive Expression of MyD88 on Dendritic Cells Is Lopez Kostka Sufficient to Induce Protection against Experimental Leishmaniasis. J Invest Dermatol. 2021;doi: 10.1016/j.jid.2021.07.184.
Lopez Kostka, S., Kautz-Neu, K., Yogev, N., Lukas, D., Holzmann, B., Waisman, A., Clausen, B. E., & von Stebut, E. (2021). Exclusive Expression of MyD88 on Dendritic Cells Is Lopez Kostka Sufficient to Induce Protection against Experimental Leishmaniasis. The Journal of investigative dermatology, . https://doi.org/10.1016/j.jid.2021.07.184
Lopez Kostka, Susanna, et al. "Exclusive Expression of MyD88 on Dendritic Cells Is Lopez Kostka Sufficient to Induce Protection against Experimental Leishmaniasis." The Journal of investigative dermatology vol. (2021). doi: https://doi.org/10.1016/j.jid.2021.07.184
Lopez Kostka S, Kautz-Neu K, Yogev N, Lukas D, Holzmann B, Waisman A, Clausen BE, von Stebut E. Exclusive Expression of MyD88 on Dendritic Cells Is Lopez Kostka Sufficient to Induce Protection against Experimental Leishmaniasis. J Invest Dermatol. 2021 Sep 24; doi: 10.1016/j.jid.2021.07.184. Epub 2021 Sep 24. PMID: 34570998.
Copy Download .nbib Format: NLM
Showing 37 to 48 of 276 entries